Physicians' Academy for Cardiovascular Education

ACS & Diabetes

Slides (presentation) - Sep. 18, 2012

ACS and Diabetes
Potential role of new antidiabetic therapies

Presented by prof John Betteridge, University College London, United Kingdom
At PACE Snapshot meeting, August 24, 2012 in Munich

View presentation, click on images

RCTs intensive versus standard glycaemic
diabetes & vascular disease
Diabetes CV guidance
Pathogenesis of Hyperglycaemia
Glucagon –like Peptide 1 (GLP1)
Insulin Secretion Cellular Processes
DPP4 - EASD Lisbon
Insulin Secretion in the Beta Cell
TAK-875 or glimepiride
TAK-875 or glimepiride
PPAR alpha and gamma
Benefits of Pioglitazone: Lipid Metabolism
HDL may promote reverse..
Aleglitazar, Fenofibric Acid and Pioglitazone
SYNCHRONY - Effects of Aleglitazar
SYNCHRONY - Aleglitazar -Lipids
Aleglitazar – ALECARDIO

The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.

Share this page with your colleagues and friends: